COVID-19 Vaccine Still Effective Against Variants: Study
The original COVID-19 vaccine still offers robust protection against variants like Delta and Omicron. A new study from the University of Arizona indicates that vaccinated individuals exhibit strong overall antibody responses, despite some nuanced findings. While the vaccine effectively combats the virus, antibody production specific to the Delta variant was slightly suppressed in those vaccinated. This research, published in Nature Immunology, shows the immune system adeptly targets unchanging parts of the virus, thus providing crucial protection. The findings suggest that antigenic imprinting might not considerably impact the immune response to SARS-CoV-2. For further insightful health reports, turn to News Directory 3. What further light will Dr. Bhattacharya’s future study shed on booster schedules? Discover what’s next.
Original COVID-19 Vaccination and Immune Response to Variants
A new study from the University of Arizona indicates that the original COVID-19 vaccine continues to offer meaningful immune protection against newer variants like delta and omicron. Researchers found that individuals vaccinated against the initial SARS-CoV-2 virus exhibited greater overall antibody production when exposed to the variants, compared to unvaccinated individuals.
Though, the study, published in Nature Immunology, also revealed a nuanced response. While the original COVID vaccine prompted a strong overall antibody response, the production of antibodies specifically targeting the delta variant was somewhat suppressed in vaccinated individuals compared to those who were unvaccinated.
According to Dr.Deepta Bhattacharya, a member of the university’s BIO5 Institute, the vaccine’s design means that the immune system still recognizes and attacks the parts of the virus that remain unchanged across variants. These antibodies, he said, are highly protective.
The research suggests that antigenic imprinting,where the initial immune response is suppressed when encountering a slightly different version of the virus,may not be functionally significant for SARS-CoV-2.
“What was really interesting is that even people whose very first exposure was to delta or to omicron, so there was no prior immunity at all, were making very poor responses against the mutant parts of the virus,” bhattacharya said.
“If you got vaccinated against the original virus strain, and then you got a delta virus infection, you made a ton of protective antibody responses but slightly fewer against the parts of the virus that had mutated compared with people who hadn’t had that vaccine,” Bhattacharya said.
What’s next
Bhattacharya plans to investigate the mechanisms behind the suppression of new antibody responses due to prior immunity. this research could inform the development of optimal vaccination and booster schedules.